Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Tops Revenue Estimates

Agios Pharmaceuticals (AGIO) came out with a quarterly loss of $1.74 per share versus the Zacks Consensus Estimate of a loss of$ 1.73. This compares to loss of $1.72 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -0.58%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of$ 16.69 per share when it actually produced earnings of $4.20, delivering a surprise of -74.84%.Over the last four quar ...